Author: GlobeNewswire

SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development…

PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that…

SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on July 10, 2021,…

Facility to Support Allogeneic CAR T, Gene Therapy, and Stem Cell-Derived Therapies Facility Able to Support Clinical Trial and Early…

Mary Kay Ladone Bioventus Board Member Bioventus Appoints Mary Kay Ladone to its Board of Directors DURHAM, N.C., July 14,…

REDWOOD CITY, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the…

EMERYVILLE, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Zogenix, a global biopharmaceutical company developing rare disease therapies, and ten U.S.…

Dr. Jack A. Ragheb as Senior Vice President, Translational ScienceMatt Schiller, Head of Business Development GAITHERSBURG, Md., July 14, 2021…

HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the…

CONSHOHOCKEN, Pa., July 13, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its first patient dosed in a…